短小芽孢杆菌质粒pCJ转化枯草杆菌的研究

本文采用我国自己分离的短小芽孢杆菌抗四环素质粒pCJ3转化枯草杆菌的各种突变体.质粒DNA经氯化铯—溴化乙锭密度梯度离心纯化后转化枯草杆菌的感受态细胞.结果表明枯草杆菌BR151,SB202,168,QB1130及QB1133都可作为质粒pCJ3的受体,转化效率在10~3左右,其中以SB202这株突变体为最高,从各种转化体中提取的质粒及经BamHI消化后的质粒的电泳图均与原质粒pCJ3及其BamHI酶切片段相同,并具有pCJ3的抗四环素转化活性.将pCJ3DNA经BamHI酶切后重新用T_4-DNA连接酶连接再转化枯草杆菌细胞,其转化效率比原质粒高1—2个数量级.研究了二价金属离子、pH及培养基成分对转化的影响,结果证明:Ca~(++)对枯草杆菌转化有促进作用,Cu~(++),Zn~(++)则有抑制作用,转化的最适pH在7.2—7.5之间;营养丰富培养能提高转化效率.     

解酚假单胞菌的分离及毒物降解的特点

在假单胞菌中有些株可以降解芳香类有机物,另一些株可以抗重金属.某些芳环化合物如苯酚等,及含汞的化合物都是可以造成环境污染的有毒物质.对假单胞菌降解水杨酸等芳香化合物的途径已有一些了解,但少有涉及代谢的调控问题.本文报道一株从化学工业污染区域新分离到的假单胞菌.这株菌不但可以降解水杨酸、苯甲酸及邻苯二酚,而且还能降解毒性较强的苯酚,并具有耐受一定浓度Hg~(2+)的能力,是一株有前途的去污染工程菌.对该菌降解混合芳香化合物的研究发现,邻苯二酚在这些芳香化合物降解代谢中是一个具有调节作用的物质.     

脉冲运动与浮体运动响应

本文以解析法推导了浮体脉冲运动时引起的速度势与浮体运动响应关系，得出由 脉冲速度势和自由表面速度势直接确定浮体运动响应函数解析式，从而使浮体运动响 应函数的计算得到简化．     

纤维硼镁矿的盐酸浸取动力学

以分段处理的方法,将纤维硼镁矿的盐酸浸取反应视作拟一级化学反应。把反应分成0—50%、50—70%及>70%三段,分别求得反应速率常数和表观活化能。当温度<80℃时,反应始终属化学反应控制;当温度>80℃时,反应前期系受液-固两相界面的传质速率控制,后期则仍属化学反应控制。这对确定生产操作条件具有重要的实践意义。     

Banach空间中微分方程的单调迭代技巧与上、下解方法

本文研究了 Banach 空间 E 中一阶微分方程的初值问题,建立了两条定理,即文中的定理2.1与定理3.1。定理2.1给出了一个比较结果。定理3.1讨论了如何用单调技巧构造单调一致收敛到方程的最小与最大解序列。参考文献[1]中的结果是本定理的一个特例.     

金属中缺陷对电化学渗氢的影响

金属中缺陷用缺陷密度G_i、陷阱能量E_i和频率因子V_i表示,氢扩散系数同这些参数的关系由简单的位能曲线模型导出.缺陷对电化学渗氢暂态的影响通过数值方法进行分析.结果表明,缺陷的存在会延迟渗氢暂态电流的出现,减小渗氢电流的变化速度.这些结论可用于解释若干异常的渗氢实验现象.文中还讨论了氢扩散系数的Arrhenius关系.     

cDNA cloning of bovine substance-K receptor through oocyte expression system

The neuropeptide receptors which are present in very small quantities in the cell and are embedded tightly in the plasma membrane have not been well characterized. Mammals contain three distinct tachykinin neuropeptides, substance P, substance K and neuromedin K, and it has been suggested that there are multiple tachykinin receptors. By electrophysiological measurement, we have previously shown that Xenopus oocytes injected with brain and stomach mRNAs faithfully express mammalian substance-P and substance-K receptors, respectively. Here we report the isolation of the cDNA clone for bovine substance-K receptor (SKR) by extending this method to develop a new cloning strategy. We constructed a stomach cDNA library with a cloning vector that allowed in vitro synthesis of mRNAs and then identified a particular cDNA clone by testing for receptor expression following injection of the mRNAs synthesized in vitro into the oocyte system. Because oocytes injected with exogenous mRNAs can express numerous receptors and channels, our new strategy will be applicable in the general molecular cloning of these proteins. The result provides the first indication that the neuropeptide receptor has sequence similarity with rhodopsin-type receptors (the G-protein-coupled receptor family) and thus possesses multiple membrane-spanning domains.     

Myosin subfragment-1 is sufficient to move actin filaments in vitro

The rotating crossbridge model for muscle contraction proposes that force is produced by a change in angle of the crossbridge between the overlapping thick and thin filaments. Myosin, the major component of the thick filament, is comprised of two heavy chains and two pairs of light chains. Together they form two globular heads, which give rise to the crossbridge in muscle, and a coiled-coil rod, which forms the shaft of the thick filament. The isolated head fragment, subfragment-1 (S1), contains the ATPase and actin-binding activities of myosin (Fig. 1). Although S1 seems to have the requisite enzymatic activity, direct evidence that S1 is sufficient to drive actin movement has been lacking. It has long been recognized that in vitro movement assays are an important approach for identifying the elements in muscle responsible for force generation. Hynes et al. showed that beads coated with heavy meromyosin (HMM), a soluble proteolytic fragment of myosin consisting of a part of the rod and the two heads, can move on Nitella actin filaments. Using the myosin-coated surface assay of Kron and Spudich, Harada et al. showed that single-headed myosin filaments bound to glass support movement of actin at nearly the same speed as intact myosin filaments. These studies show that the terminal portion of the rod and the two-headed nature of myosin are not required for movement. To restrict the region responsible for movement further, we have modified the myosin-coated surface assay by replacing the glass surface with a nitrocellulose film. Here we report that myosin filaments, soluble myosin, HMM or S1, when bound to a nitrocellulose film, support actin sliding movement (Fig. 2). That S1 is sufficient to cause sliding movement of actin filaments in vitro gives strong support to models of contraction that place the site of active movement in muscle within the myosin head.     

Expression and functional characterization of artificial mutants of interleukin-2 receptor

The physiological proliferation of T lymphocytes (T cells) requires interaction between the humoral growth factor, interleukin 2 (IL-2) and its cell-surface receptor. Studies of IL-2 binding to the IL-2 receptor (IL-2R) on T cells have revealed that there are two distinct species of IL-2R, one with high and one with low affinity. Isolation and characterization of cDNA for the human IL-2R made it possible to deduce the complete primary sequence (251 residues) of the receptor protein. However, expression of IL-2R alone is not sufficient for either growth signal transduction or high-affinity site formation: another lymphocyte-specific molecule called converter seems to be required for the biological activity of IL-2R. We found that the converter did not form a stable complex with IL-2R unless the receptor bound the ligand (the 'affinity conversion' model). To discover which are the functionally important parts of the human IL-2R we have constructed artificial mutant cDNAs encoding the receptor. The mutant receptors produced from them had deletions or substitutions in the cytoplasmic region (13 residues), the transmembrane region (19 residues) or the carboxy-terminal portion of the extracellular region (219 residues). All were active in growth signal transduction, efficient internalization and high-affinity site formation in two mouse T-cell lines, suggesting that the extracellular region of IL-2R and the converter may be responsible for growth signal transduction.     

A new immunomodulating compound (AS-101) with potential therapeutic application

There has been interest in the potential of synthetic compounds to modify immune responses by imitation of cytokine action. Direct administration of interleukin 2 (IL-2) in conjunction with adoptive transfer of lymphokine activated killer cells has been used in the treatment of cancer, but there are toxic effects resulting from the high doses of IL-2 required. We have developed a new synthetic compound, ammonium tri-chloro(dioxoethylene-O,O'-)tellurate (AS-101), which has immunomodulating properties and minimal toxicity. The effects of AS-101 on the activation and function of immunocompetent cells have been assessed. We have found that AS-101 induces proliferation and IL-2 production by human lymphocytes in vitro, and enhances the production of IL-2 and colony-stimulating factor by mouse spleen cells. Splenocytes of BALB/c mice injected with AS-101 increased production of IL-2 and CSF in vitro in the presence of mitogen. Mononuclear cells of normal donors acquired responsiveness to recombinant IL-2 and bound monoclonal antibody to IL-2 receptor after incubation with AS-101. Splenocytes of mice treated in vivo with AS-101 expressed high levels of IL-2 receptor. The stimulation of lymphocytes by AS-101 apparently involves an increase in intracellular free calcium. AS-101 administered systemically to mice mediated antitumour effects which could be attributable to its immunomodulatory properties. In addition, AS-101 could directly enhance the ratio of OKT4 to OKT8-positive cells in cultured mononuclear cells from AIDS (acquired immune deficiency syndrome) patients. These results indicate that AS-101 is potentially useful in the treatment of clinical conditions involving immunosuppression.